Effect of Antimullerian Hormone Levels on the Inflammatory Index, Phytochemical Index and NRF Nutrient Density
AMH
Investigation of Dietary Inflammatory Index, Dietary Phytochemical Index and NRF Nutrient Density in Patients With High and Low Antimullerian Hormone Levels
1 other identifier
observational
90
1 country
1
Brief Summary
The aim of the study was to calculate the dietary inflammatory index, dietary phytochemical index and NRF nutrient density of the dietary pattern routinely consumed by women and to assess whether there is a difference between PCOS patients with high AMH levels and the group with low AMH levels.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Sep 2024
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 18, 2024
CompletedFirst Posted
Study publicly available on registry
May 23, 2024
CompletedStudy Start
First participant enrolled
September 20, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
November 10, 2024
CompletedNovember 19, 2024
November 1, 2024
11 days
May 18, 2024
November 16, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
AMH levels according to dietary indexes
Patients with low, normal and high AMH values are examined for differences in the indices calculated according to nutrient density.
6 months
Study Arms (3)
Low AMH Levels-
AMH levels: those with low AMH levels (\<1.2 ng/ml): 30 participants
Normal AMH levels-
normal AMH levels (1.2-3.32 ng/ml): 30 participants
High AMH levels-
high AMH levels (\>3.32 ng/ml): 30 Participants
Interventions
The aim of this study was to compare the dietary habits of patients with PCOS and an AMH value of \>3.32 ng/ml, of patients with low ovarian reserve without PCOS and an AMH value of less than 1.2 ng/ml and of patients with normal AMH values (between 1.2-3.32 ng/ml) according to Dietary Nutrient Density according to Dietary Inflammatory Index, Dietary Phytochemical Index and Nutrient Rich Food Index.
In the routine practice of the PCOS clinic, about 7 ml of blood is taken in a vacuum gel tube for hormonal and biochemical analysis by medical staff. The blood samples are centrifuged by the researchers at 1000xg for 20 minutes. In the next step, the supernatant part is separated and transferred to 3 mL Ependorfs. These samples are used to determine the levels of anti-Müllerian hormone (AMH), oestradiol, LH and FSH, which are routinely determined at the PCOS clinic.
Eligibility Criteria
This study was designed as a cross-sectional cohort study including individuals who were followed up in the PCOS Clinic and dietetic department of Etlik Zübeyde Hanım Gynaecology Training and Research Hospital. Patients will be divided into 3 groups according to AMH value as those with low AMH value, those with normal AMH value and those with high AMH value (11). The study will include 90 individuals who agreed to be included in the study and accepted the consent form verbally and in writing.
You may qualify if:
- Between the ages of 18 and 40,
- No underlying metabolic disease (type 2 diabetes, hypertension, diagnosed anemia),
- Female patients with AMH levels in our hospital,
- Participants attending the PCOS clinic and under the care of our hospital dietitian will be enrolled in the study.
You may not qualify if:
- Age \< 18 and \> 40 years;
- Menopause, pregnancy or breastfeeding in the last 6 months;
- Hyperandrogenism and/or biochemical hyperandrogenemia due to secondary causes, including congenital adrenal hyperplasia, androgen-secreting tumors, Cushing's syndrome, hyperprolactinemia, thyroid dysfunction, and adrenal disease),
- Pre-existing systemic or psychiatric illnesses
- Taking medication that affects carbohydrate or fat metabolism (contraceptive pills, metformin, antiepileptic drugs, antipsychotics, statins and fish oil);
- Certain nutritional therapies or hypocaloric diet in the last three months; supplementation with antioxidants, vitamins or minerals;
- Taking medications that can affect fluid balance, such as non-steroidal anti-inflammatory drugs, diuretics, etc.
- Female patients with implanted pacemakers or defibrillators due to the theoretical possibility of impaired device activity.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Etlik Zübeyde Hanım
Ankara, 06000, Turkey (Türkiye)
Related Publications (2)
Lakoma K, Kukharuk O, Sliz D. The Influence of Metabolic Factors and Diet on Fertility. Nutrients. 2023 Feb 27;15(5):1180. doi: 10.3390/nu15051180.
PMID: 36904180BACKGROUNDBarrea L, Arnone A, Annunziata G, Muscogiuri G, Laudisio D, Salzano C, Pugliese G, Colao A, Savastano S. Adherence to the Mediterranean Diet, Dietary Patterns and Body Composition in Women with Polycystic Ovary Syndrome (PCOS). Nutrients. 2019 Sep 23;11(10):2278. doi: 10.3390/nu11102278.
PMID: 31547562RESULT
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Mujde Can Ibanoglu
Ankara Etlik Zubeyde Hanım Women's Health Training and Research Hospital, Ankara, Turkey.
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- CROSS SECTIONAL
- Target Duration
- 6 Months
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assoc. Prof
Study Record Dates
First Submitted
May 18, 2024
First Posted
May 23, 2024
Study Start
September 20, 2024
Primary Completion
October 1, 2024
Study Completion
November 10, 2024
Last Updated
November 19, 2024
Record last verified: 2024-11